BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31683483)

  • 21. Protecting cognition from aging and Alzheimer's disease: a computerized cognitive training combined with reminiscence therapy.
    Barban F; Annicchiarico R; Pantelopoulos S; Federici A; Perri R; Fadda L; Carlesimo GA; Ricci C; Giuli S; Scalici F; Turchetta CS; Adriano F; Lombardi MG; Zaccarelli C; Cirillo G; Passuti S; Mattarelli P; Lymperopoulou O; Sakka P; Ntanasi E; Moliner R; Garcia-Palacios A; Caltagirone C
    Int J Geriatr Psychiatry; 2016 Apr; 31(4):340-8. PubMed ID: 26205305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomised placebo-controlled trial to differentiate the acute cognitive and mood effects of chlorogenic acid from decaffeinated coffee.
    Camfield DA; Silber BY; Scholey AB; Nolidin K; Goh A; Stough C
    PLoS One; 2013; 8(12):e82897. PubMed ID: 24349389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
    Podhorna J; Krahnke T; Shear M; Harrison JE;
    Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Systematic Review and Meta-Analysis of On-Road Simulator and Cognitive Driving Assessment in Alzheimer's Disease and Mild Cognitive Impairment.
    Hird MA; Egeto P; Fischer CE; Naglie G; Schweizer TA
    J Alzheimers Dis; 2016 May; 53(2):713-29. PubMed ID: 27176076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychometric Evaluation of the Neuropsychological Test Battery in Individuals with Normal Cognition, Mild Cognitive Impairment, or Mild to Moderate Alzheimer's Disease: Results from a Longitudinal Study.
    Harrison JE; Rentz DM; Brashear HR; Arrighi HM; Ropacki MT; Liu E
    J Prev Alzheimers Dis; 2018; 5(4):236-244. PubMed ID: 30298182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
    De Jesus Moreno Moreno M
    Clin Ther; 2003 Jan; 25(1):178-93. PubMed ID: 12637119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Menopausal hormone therapy and mild cognitive impairment: a randomized, placebo-controlled trial.
    Yoon BK; Chin J; Kim JW; Shin MH; Ahn S; Lee DY; Seo SW; Na DL
    Menopause; 2018 Aug; 25(8):870-876. PubMed ID: 29846283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of acupuncture and Chinese herbal formula for elderly adults with mild cognitive impairment: protocol for a randomized controlled trial.
    Chen Y; Zhang W; Wu H; Lao L; Xu J; Xu S
    Trials; 2019 Feb; 20(1):117. PubMed ID: 30744676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donepezil for gait and falls in mild cognitive impairment: a randomized controlled trial.
    Montero-Odasso M; Speechley M; Chertkow H; Sarquis-Adamson Y; Wells J; Borrie M; Vanderhaeghe L; Zou GY; Fraser S; Bherer L; Muir-Hunter SW
    Eur J Neurol; 2019 Apr; 26(4):651-659. PubMed ID: 30565793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the Casein-Derived Peptide Met-Lys-Pro on Cognitive Function in Community-Dwelling Adults Without Dementia: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Yuda N; Tanaka M; Yamauchi K; Abe F; Kakiuchi I; Kiyosawa K; Miyasaka M; Sakane N; Nakamura M
    Clin Interv Aging; 2020; 15():743-754. PubMed ID: 32546992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylphenidate and galantamine in patients with vascular cognitive impairment-the proof-of-principle study STREAM-VCI.
    Leijenaar JF; Groeneveld GJ; Klaassen ES; Leeuwis AE; Scheltens P; Weinstein HC; van Gerven JMA; Barkhof F; van der Flier WM; Prins ND
    Alzheimers Res Ther; 2020 Jan; 12(1):10. PubMed ID: 31910895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conscious attention defect and inhibitory control deficit in Parkinson's Disease-Mild Cognitive Impairment: A comparison study with Amnestic Mild Cognitive Impairment multiple domain.
    Cammisuli DM; Sportiello MT
    Psychiatr Danub; 2017 Dec; 29(4):437-445. PubMed ID: 29197200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Xbox 360 Kinect Cognitive Games Improve Slowness, Complexity of EEG, and Cognitive Functions in Subjects with Mild Cognitive Impairment: A Randomized Control Trial.
    Amjad I; Toor H; Niazi IK; Pervaiz S; Jochumsen M; Shafique M; Haavik H; Ahmed T
    Games Health J; 2019 Apr; 8(2):144-152. PubMed ID: 30239213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-Component Intervention Program on Habitual Physical Activity Parameters and Cognitive Function in Patients with Mild Cognitive Impairment: A Randomized Controlled Trial.
    Jeong MK; Park KW; Ryu JK; Kim GM; Jung HH; Park H
    Int J Environ Res Public Health; 2021 Jun; 18(12):. PubMed ID: 34207701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group.
    Homma A; Takeda M; Imai Y; Udaka F; Hasegawa K; Kameyama M; Nishimura T
    Dement Geriatr Cogn Disord; 2000; 11(6):299-313. PubMed ID: 11044775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial.
    Salloway S; Ferris S; Kluger A; Goldman R; Griesing T; Kumar D; Richardson S;
    Neurology; 2004 Aug; 63(4):651-7. PubMed ID: 15326237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Donepezil for vascular cognitive impairment.
    Malouf R; Birks J
    Cochrane Database Syst Rev; 2004; (1):CD004395. PubMed ID: 14974068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paraoxonase 1, B Vitamins Supplementation, and Mild Cognitive Impairment.
    Perła-Kaján J; Włoczkowska O; Zioła-Frankowska A; Frankowski M; Smith AD; de Jager CA; Refsum H; Jakubowski H
    J Alzheimers Dis; 2021; 81(3):1211-1229. PubMed ID: 33935094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physical and sociopsychological characteristics of older community residents with mild cognitive impairment as assessed by the Japanese version of the Montreal Cognitive Assessment.
    Fujiwara Y; Suzuki H; Kawai H; Hirano H; Yoshida H; Kojima M; Ihara K; Obuchi S
    J Geriatr Psychiatry Neurol; 2013 Dec; 26(4):209-20. PubMed ID: 23920040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors contributing to cognitive improvement effects of acupuncture in patients with mild cognitive impairment: a pilot randomized controlled trial.
    Kim JH; Cho MR; Shin JC; Park GC; Lee JS
    Trials; 2021 May; 22(1):341. PubMed ID: 33980288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.